Population-level effect of molecular testing and targeted therapy in patients with advanced pulmonary adenocarcinoma: a prospective cohort study
Crossref DOI link: https://doi.org/10.1007/s00428-017-2268-y
Published Online: 2017-12-02
Published Print: 2018-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Schwegler, Christine http://orcid.org/0000-0002-5104-4578
Kaufmann, Dinu
Pfeiffer, David
Aebi, Stefan
Diebold, Joachim
Gautschi, Oliver
Funding for this research was provided by:
Krebsliga Zentralschweiz (CH)
License valid from 2017-12-02